OPRX 250117 5.00C (OPRX250117C5000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

OPRX250117C5000

Watchlist

0.70
+0.10+16.67%

15min DelayTrading Jan 6 10:48 ET

0.75High0.70Low

Intraday

5D
Daily

News

Is There An Opportunity With OptimizeRx Corporation's (NASDAQ:OPRX) 49% Undervaluation?
Yahoo FinanceJan 2 06:38 ET
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
BenzingaDec 24, 2024 09:49 ET
Stifel Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsDec 24, 2024 07:31 ET · Ratings
B.Riley Financial Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $13
Moomoo NewsDec 24, 2024 05:32 ET · Ratings
JMP Securities Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsDec 23, 2024 14:31 ET · Ratings
Optimistic Buy Rating for OptimizeRx Amid Leadership Transition and Strong Financial Outlook
TipRanksDec 23, 2024 13:35 ET · Ratings

Comments

MARKET-TEST-DUMMY

Dec 7, 2024 07:49

👀

$OptimizeRx (OPRX.US)$

Jaguar8

Sep 10, 2024 07:09

NEWS

$OptimizeRx (OPRX.US)$
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing ...

Moomoo AI

Mar 15, 2024 07:14

Recent insider selling at OptimizeRx, especially by Marion Odence-Ford, may worry potential investors. The absence of insider buying and insignificant share ownership by insiders hint at possible doubts about future performance.

OptimizeRx's Stock Sinks To US$12.92, But Insiders Sold Even Lower

Moomoo AI

Dec 21, 2023 06:04

OptimizeRx's high P/S ratio may suggest that investors anticipate a turnaround in the company's revenue performance. This could indicate shareholders' strong future revenue expectations.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 06:01

The high P/S ratio at OptimizeRx suggests investors expect a reversal of the company's downtrend in revenue. Shareholders seem to hold stocks with hope for the company's promising future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%